InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Adlai Nortye Ltd.

ANL Clue Score26
United States Fiscal year ends December CIK 0001944552
$15.62 +0.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $15.62 +48.62% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Sep 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue45.7Operating income−8.6Net income−56.7EPS, diluted−2.23Fiscal year 2022Operating income−67.3Net income−58.8EPS, diluted−2.31Fiscal year 2023Revenue5.0Operating income−72.6Net income−109.2EPS, diluted−2.52Fiscal year 2024Operating income−52.9Net income−51.9EPS, diluted−0.54
FY2021FY2022FY2023FY2024
Revenue 45.7 n/a 5.0 n/a
Growth
Operating income −8.6 −67.3 −72.6 −52.9
Net income −56.7 −58.8 −109.2 −51.9
Growth
EPS, diluted −2.23 −2.31 −2.52 −0.54

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin−18.9%Net margin−124.0%Free cash flow margin−8.9%Fiscal year 2022Fiscal year 2023Operating margin−1,451.0%Net margin−2,184.6%Free cash flow margin−1,137.0%Fiscal year 2024
FY2021FY2022FY2023FY2024
Operating margin −18.9% n/a −1,451.0% n/a
Net margin −124.0% n/a −2,184.6% n/a
Free cash flow margin −8.9% n/a −1,137.0% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−3.0Capital expenditure−1.0Free cash flow−4.1Fiscal year 2022Operating cash flow−43.2Capital expenditure−1.2Free cash flow−44.5Fiscal year 2023Operating cash flow−56.7Capital expenditure−0.2Free cash flow−56.9Fiscal year 2024Operating cash flow−51.8Capital expenditure−0.2Free cash flow−52.0
FY2021FY2022FY2023FY2024
Operating cash flow −3.0 −43.2 −56.7 −51.8
Capital expenditure −1.0 −1.2 −0.2 −0.2
Free cash flow −4.1 −44.5 −56.9 −52.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash64.1Shareholders’ equity−185.4Fiscal year 2022Cash42.8Shareholders’ equity−241.3Fiscal year 2023Cash91.5Shareholders’ equity75.0Fiscal year 2024Cash60.9Shareholders’ equity25.5
FY2021FY2022FY2023FY2024
Cash 64.1 42.8 91.5 60.9
Shareholders’ equity −185.4 −241.3 75.0 25.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Margins
−18.9% n/a −1,451.0% n/a
−124.0% n/a −2,184.6% n/a
−124.0% n/a −2,184.6% n/a
−8.9% n/a −1,137.0% n/a
Spending
92.1% n/a 1,163.0% n/a
n/a n/a 305.8% n/a
2.2% n/a 4.0% n/a
Returns
n/a n/a −145.5% −203.5%
n/a −81.0% −83.9% −72.8%
Balance and payout
n/a 432.4% 42.4% 64.2%